4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 1,300.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,820.00p
  • 52 Week Low: 545.00p
  • Currency: UK Pounds
  • Shares Issued: 15.48m
  • Volume: 2
  • Market Cap: £201.21m
  • Beta: 0.18

Key dates

Dividend  
Latest XD Date n/a
Latest Pay Date n/a
   
Meetings  
AGM 28-Jun-2024
EGM n/a
GMs n/a
   
Announcements  
Trading announcement n/a
IMSs n/a
Drilling Report n/a
   
Results  
Final results 09-May-2022
Interim results 27-Sep-2024
Q1 Results n/a
Q2 Results n/a
Q3 Results n/a
Q4 Results n/a
Annual Report 05-Jun-2024
   
Year End n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

4basebio Market Data

Currency UK Pounds
Share Price 1,300.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,820.00p
52 Week Low 545.00p
Volume 2
Shares Issued 15.48m
Market Cap £201.21m
Beta 0.18

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.57% below the market average25.57% below the market average25.57% below the market average25.57% below the market average25.57% below the market average
28.00% above the sector average28.00% above the sector average28.00% above the sector average28.00% above the sector average28.00% above the sector average
Price Trend
70.60% above the market average70.60% above the market average70.60% above the market average70.60% above the market average70.60% above the market average
95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average
Income Not Available
Growth
35.67% above the market average35.67% above the market average35.67% above the market average35.67% above the market average35.67% above the market average
35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average

4basebio Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:04 2 @ 1,310.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page